Global Oncology/Cancer Drugs Market Research Report 2016

January 2017 | 104 pages | ID: G82168A1941EN
QYResearch

Abstracts

Notes:

Production, means the output of Oncology/Cancer Drugs

Revenue, means the sales value of Oncology/Cancer Drugs

This report studies Oncology/Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Roche
• Novartis
• Celgene
• Amgen
• Johnson & Johnson
• GlaxoSmithKline
• Eli lilly & Co
• Pfizer
• Merck & Co.
• Sanofi

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Oncology/Cancer Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Others

Split by application, this report focuses on consumption, market share and growth rate of Oncology/Cancer Drugs in each application, can be divided into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Contents

Global Oncology/Cancer Drugs Market Research Report 2016

1 ONCOLOGY/CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology/Cancer Drugs
1.2 Oncology/Cancer Drugs Segment by Type
  1.2.1 Global Production Market Share of Oncology/Cancer Drugs by Type in 2015
  1.2.2 Blood Cancer
  1.2.3 Breast Cancer
  1.2.4 Gastrointestinal Cancer
  1.2.5 Prostate Cancer
  1.2.6 Others
1.3 Oncology/Cancer Drugs Segment by Application
  1.3.1 Oncology/Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Chemotherapy
  1.3.3 Targeted Therapy
  1.3.4 Immunotherapy (Biologic Therapy)
  1.3.5 Hormonal Therapy
  1.3.6 Others
1.4 Oncology/Cancer Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Status and Prospect (2011-2021)
  1.4.6 Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Oncology/Cancer Drugs (2011-2021)

2 GLOBAL ONCOLOGY/CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Oncology/Cancer Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Oncology/Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Oncology/Cancer Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Oncology/Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oncology/Cancer Drugs Market Competitive Situation and Trends
  2.5.1 Oncology/Cancer Drugs Market Concentration Rate
  2.5.2 Oncology/Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ONCOLOGY/CANCER DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Oncology/Cancer Drugs Capacity and Market Share by Region (2011-2016)
3.2 Global Oncology/Cancer Drugs Production and Market Share by Region (2011-2016)
3.3 Global Oncology/Cancer Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ONCOLOGY/CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Oncology/Cancer Drugs Consumption by Regions (2011-2016)
4.2 North America Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 Oncology/Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ONCOLOGY/CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Oncology/Cancer Drugs Production and Market Share by Type (2011-2016)
5.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Oncology/Cancer Drugs Price by Type (2011-2016)
5.4 Global Oncology/Cancer Drugs Production Growth by Type (2011-2016)

6 GLOBAL ONCOLOGY/CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Oncology/Cancer Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Oncology/Cancer Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ONCOLOGY/CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Roche Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Novartis
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Novartis Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Amgen Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Johnson & Johnson Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Eli lilly & Co
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Eli lilly & Co Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Pfizer
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Pfizer Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Merck & Co.
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Merck & Co. Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Sanofi
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Oncology/Cancer Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Sanofi Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 ONCOLOGY/CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Oncology/Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology/Cancer Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Oncology/Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology/Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ONCOLOGY/CANCER DRUGS MARKET FORECAST (2016-2021)

12.1 Global Oncology/Cancer Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Oncology/Cancer Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Oncology/Cancer Drugs Production Forecast by Type (2016-2021)
12.4 Global Oncology/Cancer Drugs Consumption Forecast by Application (2016-2021)
12.5 Oncology/Cancer Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology/Cancer Drugs
Figure Global Production Market Share of Oncology/Cancer Drugs by Type in 2015
Figure Product Picture of Blood Cancer
Table Major Manufacturers of Blood Cancer
Figure Product Picture of Breast Cancer
Table Major Manufacturers of Breast Cancer
Figure Product Picture of Gastrointestinal Cancer
Table Major Manufacturers of Gastrointestinal Cancer
Figure Product Picture of Prostate Cancer
Table Major Manufacturers of Prostate Cancer
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Oncology/Cancer Drugs Consumption Market Share by Application in 2015
Figure Chemotherapy Examples
Figure Targeted Therapy Examples
Figure Immunotherapy (Biologic Therapy) Examples
Figure Hormonal Therapy Examples
Figure Others Examples
Figure North America Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Oncology/Cancer Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Oncology/Cancer Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Oncology/Cancer Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Oncology/Cancer Drugs Capacity of Key Manufacturers in 2015
Figure Global Oncology/Cancer Drugs Capacity of Key Manufacturers in 2016
Table Global Oncology/Cancer Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Oncology/Cancer Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology/Cancer Drugs Production Share by Manufacturers
Figure 2016 Oncology/Cancer Drugs Production Share by Manufacturers
Table Global Oncology/Cancer Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Oncology/Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Oncology/Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Oncology/Cancer Drugs Revenue Share by Manufacturers
Table Global Market Oncology/Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Oncology/Cancer Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Oncology/Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology/Cancer Drugs Product Type
Figure Oncology/Cancer Drugs Market Share of Top 3 Manufacturers
Figure Oncology/Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Oncology/Cancer Drugs Capacity by Regions (2011-2016)
Figure Global Oncology/Cancer Drugs Capacity Market Share by Regions (2011-2016)
Figure Global Oncology/Cancer Drugs Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Oncology/Cancer Drugs Capacity Market Share by Regions
Table Global Oncology/Cancer Drugs Production by Regions (2011-2016)
Figure Global Oncology/Cancer Drugs Production and Market Share by Regions (2011-2016)
Figure Global Oncology/Cancer Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Oncology/Cancer Drugs Production Market Share by Regions
Table Global Oncology/Cancer Drugs Revenue by Regions (2011-2016)
Table Global Oncology/Cancer Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Oncology/Cancer Drugs Revenue Market Share by Regions
Table Global Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Oncology/Cancer Drugs Consumption Market by Regions (2011-2016)
Table Global Oncology/Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Oncology/Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Oncology/Cancer Drugs Consumption Market Share by Regions
Table North America Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table China Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Oncology/Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Oncology/Cancer Drugs Production by Type (2011-2016)
Table Global Oncology/Cancer Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Oncology/Cancer Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Oncology/Cancer Drugs by Type
Table Global Oncology/Cancer Drugs Revenue by Type (2011-2016)
Table Global Oncology/Cancer Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Oncology/Cancer Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Oncology/Cancer Drugs by Type
Table Global Oncology/Cancer Drugs Price by Type (2011-2016)
Figure Global Oncology/Cancer Drugs Production Growth by Type (2011-2016)
Table Global Oncology/Cancer Drugs Consumption by Application (2011-2016)
Table Global Oncology/Cancer Drugs Consumption Market Share by Application (2011-2016)
Figure Global Oncology/Cancer Drugs Consumption Market Share by Application in 2015
Table Global Oncology/Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Oncology/Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Oncology/Cancer Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Oncology/Cancer Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Oncology/Cancer Drugs Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Oncology/Cancer Drugs Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Oncology/Cancer Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Oncology/Cancer Drugs Market Share (2011-2016)
Table Eli lilly & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli lilly & Co Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli lilly & Co Oncology/Cancer Drugs Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Oncology/Cancer Drugs Market Share (2011-2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Oncology/Cancer Drugs Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Oncology/Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Oncology/Cancer Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology/Cancer Drugs
Figure Manufacturing Process Analysis of Oncology/Cancer Drugs
Figure Oncology/Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology/Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Oncology/Cancer Drugs
Table Distributors/Traders List
Figure Global Oncology/Cancer Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Oncology/Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Oncology/Cancer Drugs Production Forecast by Regions (2016-2021)
Table Global Oncology/Cancer Drugs Consumption Forecast by Regions (2016-2021)
Table Global Oncology/Cancer Drugs Production Forecast by Type (2016-2021)
Table Global Oncology/Cancer Drugs Consumption Forecast by Application (2016-2021)